ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2026
Correction to 'Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 years'.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.